Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

Doctors' views on pharma: part three

As our medical communications month continues, we speak with our third healthcare professional about how communication between pharma and physicians can be improved. To coincide with our medical communications focus month, pharmaphorum speaks with five healthcare professionals to...

Articles

Innovation in the pharma industry (part 2): what challenges ...

In the second of a four-part video series on ‘Innovation in the pharma industry’, several attendees of Cegedim Relationship Management’s life science event share their thoughts on what challenges pharma faces in implementing innovation. What are the blocks preventing pharma from implementing innovation? We asked several...

Articles

Innovation in the pharma industry (part 3): what can help ph...

In the third of a four-part video series on innovation in pharma, several attendees of Cegedim Relationship Management’s life science event share their thoughts on what can help pharma to drive innovation. Previously in this series, we addressed how well pharma is currently driving innovation and what challenges there are to implementing...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital